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proteins lead to myopathies and cardiomyopathies. Deletion of the 14 C-terminal residues of cardiac troponin T leads to hyper-
trophic cardiomyopathy. We showed earlier that regulated actin containing D14 TnT was more readily activated than wild-type
regulated actin. We suggested that the equilibria among the inactive (blocked), intermediate (closed or calcium), and active
(open or myosin) states was shifted to the active state. We now show that, in addition, such regulated actin filaments cannot
enter the inactive or blocked state. Regulated actin containing D14 TnT had ATPase activities in the absence of Ca2þ that
were higher than wild-type filaments but far below the fully active rate. The rapid dissociation of S1-ATP from regulated actin
filaments containing D14 TnT and acrylodan-labeled tropomyosin did not show the fluorescence increase characteristic of
moving to the inactive state. Replacing wild-type TnI with S45E TnI, that favors the inactive state, did not restore the fluores-
cence change. We conclude that TnT has a previously unrecognized role in forming the inactive state of regulated actin.INTRODUCTIONCardiac and skeletal muscles are regulated by the actin
binding proteins tropomyosin, troponin I, troponin T, and
troponin C. The complex of actin, tropomyosin, and the
three troponin components leads to regulated actin with
varied abilities to stimulate the ATPase activity of myosin.
The presence of high-affinity interactions with myosin
stabilizes the active state. Saturating Ca2þ favors the forma-
tion of the intermediate state. In the absence of high-affinity
myosin interactions or Ca2þ, the regulated actin is inactive.
Alterations in troponin, such as disease-causing muta-
tions, may lead to changes in distribution of states of the
regulatory complex (1–3), resulting in ATPase rates that
are too high or too low. If the distribution of states could
be normalized it might be possible to avoid the progression
to heart failure. Molecular dynamics simulations (4) and
experimental results (5,6) show close coupling of the
components of the troponin complex. This close coupling
raises the possibility that an abnormal distribution of states
might be corrected by perturbing troponin at a site distant
from initial mutation. However, before such an approach
is to be taken, it is necessary to understand more clearly
the role of the TnT, TnI, and TnC subunits of troponin.
The TnT subunit of troponin is sometimes thought of as
a glue that holds TnI and TnC to tropomyosin (7). TnT is
thought to be involved in obtaining full activation of contrac-
tion but is not considered to play a key role in the inactivation
process. Our work shows that TnT may play an essential role
in maintaining the inactive state of regulated actin.
Deletion of the 14 C-terminal residues of TnT resulted in
higher actin-activated ATPase activity in the presence andSubmitted November 8, 2011, and accepted for publication April 24, 2012.
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0006-3495/12/06/2536/9 $2.00absence of Ca2þ relative to wild-type when normalized to
the maximum possible activation obtained in the presence
of the activator NEM-S1 (3). Those results were interpreted
as stabilization of the active state of regulated actin by
D14 TnT (3).
We now show from an analysis of ATPase activities and
from changes in acrylodan-tropomyosin fluorescence that
deletion of those 14 residues of TnT also restricted entry
of regulated actin into the inactive state. That restriction
was severe and could not be rescued by a TnI mutant
(S45E) that favors the inactive state (3). The S45E mutation
of TnI mimics protein kinase C phosphorylation of TnI (2).METHODS
Proteins
Actin (8) and skeletal muscle troponin (9) were prepared from rabbit back
muscle. Myosin was prepared either from rabbit back muscle (10) or
porcine left ventricle (11,12). Myosin S1 was prepared by chymotryptic
digestion of myosin (12,13). Cardiac S1 was further purified by cosedimen-
tation with equimolar actin at 0.3 M KCl buffer and 1 mM MgATP (14).
Cardiac muscle tropomyosin (15) and troponin (16) were prepared from
bovine cardiac left ventricles. Human cardiac troponin TnT (isoform 2) in
pSBETa, TnC in pET3d, human cardiac TnI in pET17b, and mouse cardiac
TnI in pET3d were expressed and purified as previously described (3,17).
Troponin subunits were reconstituted following the previously described
protocol (17) with some modifications. TnT, TnI, and TnC were mixed at
a 1:1:1.2 molar ratio and a Protein Pak DEAE 15HR column (Waters, Mil-
ford, MA) was used for final purification with start buffer of 0.1 M NaCl,
20 mM Tris-HCl pH 8.0, and 5 mM MgCl2. Troponin was eluted with
a 0.1–1.0 M NaCl gradient in the same buffer. The troponin used was either
all human cardiac or else a hybrid formed from human cardiac TnTand TnC
and mouse cardiac TnI. The latter combination allowed us to use a phospho-
mimetic mutant of that TnI that stabilized the inactive state.
Protein concentrations were determined using the following extinction
coefficients: (ε 0.1%) for 280-nm: actin, 1.15 and myosin S1, 0.75. Concen-
trations of tropomyosin and troponin subunits were determined withdoi: 10.1016/j.bpj.2012.04.037
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proteins were assumed to be actin, 42,000; myosin S1, 120,000; tropomy-
osin, 68,000; troponin I, 24,000; troponin T, 35,923; and troponin C,
18,400.Actin-activated myosin S1 ATPase rates
ATPase rates were measured by the rate of liberation of 32Pi from g
32P-ATP
(18). Assays were measured at 25C in reactions containing 0.1 mM S1,
10 mM F-actin, and variable amounts of tropomyosin and troponin in
a buffer containing 1 mM ATP, 3 mM MgCl2, 34 mM NaCl, 10 mM
MOPS, 1 mM dithiothreitol, 2 mM EGTA, or 0.1 mM CaCl2, pH 7.
ATPase rates were measured as a function of tropomyosin concentrations
up to 9.4 mM at an actin concentration of 10 mM. Rates for skeletal S1
decreased from 1.1/s to 0.44/s at tropomyosin concentrations in excess of
0.71 mM (data not shown). A quantity of 2.2 mM tropomyosin was used
in most ATPase experiments.
N-ethylmaleimide-treated S1 (NEM-S1) was used to stabilize the active
state of regulated actin when ATP was present (19). NEM-S1 was prepared
by reacting 4 mg/ml myosin S1 with a 15-fold molar excess of N-ethylma-
leimide at 25C for 30 min (20). In ATPase assays, the concentration of
regulated actin was increased by an amount equal to the added NEM-S1
concentration to maintain a constant free regulated actin concentration (19).Fluorescence time courses
Acrylodan-labeled cardiac muscle tropomyosin was prepared as described
for skeletal muscle tropomyosin (21) using a 10:1 molar ratio of acrylodan
or N-(1-pyrene)iodoacetamide to tropomyosin. These conditions gave
>70% labeling.
Rapid kinetic measurements were made with a SF20 sequential mixing
stopped-flow spectrometer (Applied Photophysics, Leatherhead, UK). A
monochromator was used to set the excitation wavelength; the slit width
was 0.5 mm. Acrylodan was excited with light at a wavelength of
391 nm and fluorescence was measured through a Schott GG 455 (Duryea,
PA) long-pass filter with a 455-nm midpoint or a 450-nm long-pass filter
(Edmund Optics, Barrington, NJ). Light-scattering measurements were
generally made simultaneously with acrylodan fluorescence measurements
using a 425-nm short-pass filter that rejects light between 435 and 635 nm
(Edmund Optics).ATP chase studies
Amixture of 4 mMF-actin, 1.7 mM acrylodan-labeled bovine cardiac tropo-
myosin, 1.7 mM troponin, and 4 mM myosin S1 were rapidly mixed with
a solution containing 4 mM ATP. At these concentrations, the skeletal
S1-ATP complex dissociated very rapidly from actin allowing actin-tropo-
myosin-troponin to return first to the intermediate state (the major state in
Ca2þ) and then to the inactive state (the major state in EGTA). The transi-
tion from the active state to the intermediate state occurred with a decrease
in acrylodan fluorescence whereas the subsequent transition to the inactive
state occurred with an increase in fluorescence as reported with skeletal
tropomyosin-troponin (21). Cardiac S1 was used in some studies, but due
to its slower dissociation from actin, the kinetics of thin filament transitions
were not readily determined.
The reaction can be described by the scheme shown in Eq. 1 where M is
myosin, A is actin in the active state, and X and I represent the intermediate














(1)At high ATP concentrations and with skeletal S1 the values of k1 and k2
were sufficiently high that subsequent transitions were unaffected (cardiac
S1 produced more complex kinetics). Simulations were done only on rate
constants k3–k8. The differential equations used to simulate the ATP chase
studies were shown earlier (21). S1-ATP detachment was measured by light
scattering and was simulated adjusting k3 so that d[ATP-M-A]/dt matched
measured traces. Because the detachment of S1-ATP is virtually complete
under the conditions used here, the value of k4 was set to zero.
Transitions from the active state to the intermediate and inactive states
were simulated by varying k5 and k7 to match the time courses of A, X,
and I to match the observed fluorescence transient. In fitting the data, the
observed fluorescence was set equal to
FA  ½A þ FX  ½X þ FI  ½I;
where FA, FX, and FI are the relative fluorescence intensities of states A, X,
and I, respectively. The relative fluorescence of state A, FA, was set to 1.
The value of FI was 0.95 and FX was permitted to float in simulations.Definition of actin states
We previously described the states of regulated actin in the following way:
state 10 (inactive state with no bound Ca
2þ), state 12 (inactive state with two
bound Ca2þ), and state 2 (active state) (22). The ATPase activities of
myosin S1 in the presence of regulated actin in these states are inactive,
intermediate, and active, respectively, and we use those model-independent
descriptors of activity here. Another notation is B (blocked) for the state in
the absence of Ca2þ or bound S1, C (closed or Ca2þ) for the major state
populated at saturating Ca2þ, and M (myosin) for the myosin-activated
state. That notation comes from studies of myosin S1 binding to actin in
the absence of ATP (23–25) and is not totally appropriate in this case. There
is no blocked state in the presence of ATP at ionic strengths ranging from 18
to 134 mM in solution (18,26,27) and up to 170 mM ionic strength in single
fibers (28).RESULTS
We employed ATPase assays and acrylodan tropomyosin
fluorescence changes to determine the effect of the D14
mutation of TnT on the occupancy of the inactive state of
regulated actin. When normalized to the maximum and
minimum possible rates, ATPase assays give a functional
measure of the occupancy of the active state. Acrylodan
tropomyosin fluorescence changes give a measure of the
occupancy of the inactive state.
Mutations of troponin may weaken binding to actin-
tropomyosin. Fig. 1 shows the dependencies of ATPase rates
on the concentrations of troponin (human cardiac TnT and
TnC with mouse cardiac TnI) in the absence and presence
of Ca2þ. In the absence of Ca2þ, minimum ATPase activities
were reached at ~3 mM troponin in all cases (Fig. 1 A). No
clear differences were seen in affinity among different
troponin types at saturating Ca2þ. Concentrations of
troponin sufficient to achieve an optimal effect in EGTA
were more than adequate to achieve saturation at saturating
Ca2þ. Note that the S45E TnI mutant produced a level of
activity similar to that of actin and tropomyosin alone and
no apparent effect of adding troponin was observed at satu-
rating Ca2þ.Biophysical Journal 102(11) 2536–2544
FIGURE 1 Rate of actin-tropomyosin activated myosin S1 ATPase
activity as a function of troponin concentration in the absence (A) and pres-
ence (B) of Ca2þ. Wild-type cardiac troponin (circles), S45E-TnI contain-
ing troponin (inverted triangles), D14 TnT containing troponin (triangles),
double troponin mutant D14 TnT/S45E TnI (diamonds), and skeletal
troponin (crosses). Conditions: 10 mM actin, 2.2 mM tropomyosin, 0.71–
4.3 mM troponin (either human cardiac TnT and TnC with mouse cardiac
TnI or rabbit skeletal troponin), and 0.1 mM skeletal S1 at 25C in
34 mM NaCl, 10 mM MOPS, 3 mM MgCl2, 0.1 mM CaCl2 or 2 mM
EGTA, 1 mM dithiothreitol, pH 7.
2538 Franklin et al.Mutations of troponin affected the ability of regulated
actin to stimulate the ATPase activity of skeletal myosin
S1. Table 1 summarizes those results. In the absence of
Ca2þ, the S45E TnI mutant was slightly more inhibitory
than wild-type cardiac troponin. Regulated actin filaments
containing D14 TnT were significantly less inhibitory than
the wild-type filaments. Regulated actin filaments contain-
ing both S45E TnI and D14 TnT (double mutant) were
also less inhibitory than wild-type filaments and resembledTABLE 1 Skeletal S1 ATPase rates with wild-type regulated











D14TnT 0.16 2.6 10 0.015 0.29
D14TnT/S45E TnI 0.14 1.9 9.2 0.013 0.2
Wild-type 0.028 1.7 9.7 0.0011 0.18
S45E TnI 0.017 0.52 10 0 0.048
10 mM actin, 2.2 mM tropomyosin,R 2.9 mM troponin, 0.1 mM S1 at 25C
in the buffer listed in Fig. 1. The rate of S1 alone was 0.07/s and acto-S1
was 1.1/s.
*Normalized rate ¼ (vobs-vmin)/(vnem-vmin). An average value of vnem was
used, 9.7/s.
Biophysical Journal 102(11) 2536–2544filaments containing D14 TnT alone. Rabbit skeletal
troponin, shown as a control, produced a similar degree of
inhibition with cardiac tropomyosin as did cardiac troponin
but had a greater affinity for the actin-tropomyosin complex.
In the presence of saturating Ca2þ, regulated actin
produced maximum ATPase rates with the order: D14
TnT > double mutant > wild-type > S45E TnI. The double
mutant had a Ca2þ-activated ATPase rate that was between
the rates observed for both single mutants. Thus the reduced
activation of the S45E TnI mutant compensated for the
superior activation of the D14 TnT mutant in saturating
Ca2þ. Competing effects of these mutants did not occur in
the absence of Ca2þ. The lack of compensation in EGTA
indicated that the D14 TnT containing actin filaments could
not enter the inactive state.
Cardiac S1 ATPase rates were measured with the same
hybrid regulated actin filaments. Poor regulation of
ATPase activity was obtained unless the S1 was purified
as described in Methods. The D14 TnT mutant enhanced
the regulated actin-activated ATPase activity by 8.2-fold
in EGTA (0.14/s vs. 0.017/s) and 2.4-fold in Ca2þ (0.60/s vs.
0.25/s). The S45E TnI mutant reduced the activity to
0.53 in EGTA (0.009/s vs. 0.017/s) and 0.68 in Ca2þ
(0.17/s vs. 0.25/s).
Similar results were obtained with skeletal S1 and
troponin containing all human cardiac subunits. In the pres-
ence of Ca2þ, the ATPase rate with regulated actin contain-
ing D14 troponin was ~2-fold greater than wild-type
(1.6/s vs. 0.83/s). In the absence of Ca2þ, the ATPase rate
with regulated actin containing D14 TnT was ~3-fold of
the wild-type value (0.14/s vs. 0.05/s). All ATPase studies
suggested that D14 TnT stabilized the active state and desta-
bilized the inactive state of regulated actin.
Full stabilization of the active state of regulated actin was
achieved by using N-ethylmaleimide labeled S1 (NEM-S1).
NEM-S1 stabilizes the active state even in the presence of
ATP but contributes little to the observed ATP hydrolysis.
Fig. 2 shows the NEM-S1 dependencies of skeletal S1
ATPase in the presence of regulated actin having different
types of troponin. The solid lines are best fits of a hyperbolic
curve to each data set. The rates at high NEM-S1 were rela-
tively independent of mutations in TnT or TnI.
The concentration of NEM-S1 required to give 50% of the
limiting ATPase rate increased in order: S45E TnI > wild-
type > double mutant > D14 TnT (Fig. 2), confirming that
D14 TnT containing thin filaments were more readily acti-
vated than those containing wild-type troponin. This was
another indication that the distributions between the interme-
diate and active states were additive for the two mutants.
The patterns for the ease of activation with NEM-S1 as
well as the results of Fig. 1 are consistent with our earlier
results (2,3) that D14 TnT stabilized the active state and
S45E TnI destabilized the active state. This can be seen
from the effect of the mutants on the fraction of actin in
the active state as given by normalized ATPase rates
FIGURE 2 NEM-S1 stimulation of actin-tropomyosin-troponin activa-
tion of myosin S1 ATPase activities at saturating Ca2þ. Wild-type troponin
(circles), S45E TnI containing troponin (inverted triangles), D14 TnT con-
taining troponin (triangles), double troponin mutant D14 TnT/S45E TnI
(diamonds). Rates were corrected for contributions from free S1 and
NEM-S1. (Solid lines) Best fits to each individual curve. The rates at
zero NEM-S1 in reciprocal seconds were 0.52 for S45E TnI, 1.7 for
wild-type, 1.9 for the double mutant, and 2.6 for D14 TnT. The limiting
ATPase rates in reciprocal seconds were 0.78 for S45E TnI, 1.7 for wild-
type, 2.6 for the double mutant, and 3.6 for D14 TnT. The average limiting
ATPase rate was 9.7/s. The micromolar concentrations of NEM-S1 required
for half-maximum activation were 6, 4, 1.7, and 1.6 for S45E TnI, wild-
type, double mutant, and D14 TnT, respectively. Initial conditions were
the same as in Fig. 1, except 2.9 mM troponin was used and the concentra-
tion of regulated actin was raised along with NEM-S1 (see Methods).
FIGURE 3 Time courses of light scattering (A) and acrylodan tropomy-
osin fluorescence (B) changes after rapid S1-ATP detachment from actin-
tropomyosin-troponin. (Curve 1) Light scattering in EGTA, kapp ¼ 700/s.
(Curve 2) Light scattering in Ca2þ, kapp ¼ 570/s. (Curve 3) Fluorescence
in EGTA, kapp1¼ 790/s, kapp2¼ 18/s. (Curve 4) Fluorescence in Ca2þ, kapp1¼
670/s. Conditions: 2 mM actin, 0.86 mM tropomyosin, 0.86 mM troponin
(human cardiac TnT and TnC with mouse cardiac TnI), 2 mM skeletal S1
in 2 mM ATP, 142 mM KCl, 20 mM MOPS, 6 mM MgCl2, 1 mM dithio-
threitol, and either 2 mM EGTA or 0.2 mM CaCl2 at 25
C, pH 7.
The C-Terminus of Troponin T 2539(Table 1). The lowest ATPase rate measured was that with
regulated actin containing S45E TnI in EGTA; that rate
was set equal to zero. The limiting rate at high NEM-S1
was set to 1.
The failure of the S45E TnI mutant to rescue the D14 TnT
mutant in the absence of Ca2þ could be explained by an
inability of D14 TnT containing regulated actin to form
the inactive state. The transition to the inactive state can
be measured directly using an acrylodan probe on tropomy-
osin (21).
Fig. 3 A shows time courses of S1-ATP detachment from
actin-tropomyosin-troponin as measured by light scattering.
Ca2þ had little effect on the rate constant for skeletal
S1-ATP detachment. Fig. 3 B shows changes in fluorescence
emission intensity from acrylodan-tropomyosin that were
measured simultaneously with the light-scattering changes.
Acrylodan-tropomyosin fluorescence decreased rapidly, in
the presence of Ca2þ, with a rate constant that was similar
to that of the light-scattering transition. The rapid decrease
in fluorescence represented the change from the active state
to an equilibrium mixture of states dominated by the inter-
mediate state. Therefore, the rate of transition of tropomy-
osin to the intermediate state was greater or equal to the
rate of dissociation of S1-ATP from regulated actin.
In the absence of Ca2þ, the rapid fluorescence decrease
was followed by a slower fluorescence increase as regulated
actin moved to the inactive state (Fig. 3 B).Conditions for measuring the transition from the active
state to the intermediate and inactive states were optimized
by varying concentrations of troponin, S1, and ATP. The
initial rapid decrease in acrylodan fluorescence was insensi-
tive to the troponin concentration. Increasing troponin from
0.43 to 0.86 mM produced a change in the slower fluores-
cence increase from a biexponential to a monoexponential
signal (data not shown). At low troponin concentrations
the slow fluorescence increase was preceded by a more rapid
increase. We used the presence of a monoexponential
increase as evidence of troponin saturation.
The largest amplitudes for the fluorescence transitions
occurred when the ratio of bound S1 to actin was 1:1. The
amplitude of the signal approached zero as the S1 concen-
tration approached zero. No changes in kinetics were
observed among traces of different S1 concentrations where
a signal was observed (data not shown).Biophysical Journal 102(11) 2536–2544
2540 Franklin et al.Transients of acrylodan tropomyosin fluorescence, after
dissociation of skeletal S1-ATP, changed qualitatively as
the ATP concentration was decreased (Fig. 4 A). The fluo-
rescence redevelopment characteristic of entering the inac-
tive state was not seen at 0.05 mM ATP. The transition to
the inactive state was first observed at 0.1 mM ATP but
the observed rate was very slow and limited by the slow
rate of S1-ATP detachment. Accurate measurement of the
kinetics of transition to the inactive state required rapid
ATP binding and rapid detachment of S1-ATP.
Fig. 4 B shows a plot of apparent rate constants for the
transition to the intermediate and inactive states at z11C
at varied concentrations of ATP. Fig. 4 C shows the same
at z2C. Measurements of the apparent rate constant for
formation of the inactive state were approximately constant
above 0.5 mM ATP at both temperatures.
Similar studies were done with cardiac S1 but the result-
ing kinetics were complicated by a population of slowly
detaching cardiac S1. The population of slowly detaching
S1 was reduced, but not eliminated, by removing ATP
resistant S1 as described in Methods. Fig. 4 D shows thatBiophysical Journal 102(11) 2536–2544after dissociation of cardiac S1-ATP there was a rapid
decrease in fluorescence followed by a slower fluorescence
recovery that occurred only when ATP was in excess of
0.1 mM. The slow fluorescence increase had a smaller
amplitude with cardiac S1 than observed with skeletal
S1. Simulations of the data indicated that the reduced
amplitude resulted from slower cardiac S1 detachment
rates.
Fig. 4 E shows the rate of light-scattering decrease after
rapid addition of ATP to the complex of cardiac S1 bound
to regulated actin. The dissociation of purified cardiac S1
from regulated actin was biexponential. The apparent rate
constants for each process are shown together with the frac-
tion of the light scattering signal due to the fast process
(inset). Although the rate of the fast process was near
600/s at high ATP concentrations, the slow phase did not
exceed 40/s. At 10 mM ATP, the slow phase accounted for
20% of the total signal and limited the kinetics of the subse-
quent transitions of regulated actin.
Fig. 4 F shows the ATP dependence of the apparent rate
constants for actin transitions measured by the dissociationFIGURE 4 ATP dependence of the kinetics of
acrylodan fluorescence changes during transition
from the active state to the inactive state of actin-
tropomyosin-troponin. Panels A–C are experiments
with skeletal S1. (A) Time courses at 11C for
acrylodan tropomyosin fluorescence changes at
various [ATP] given as mM in the figure. (B and
C) Apparent rate constants for the transitions to
the inactive state and to the intermediate state
(inset) at varied [ATP] at 11C (B) and 2C (C).
(Open circles) Apparent rate constants for the
acrylodan tropomyosin fluorescence transitions;
(squares) apparent rate constants for light-scat-
tering transitions. (D–F) Experiments with cardiac
S1. (D) Time courses at 7C for acrylodan tropo-
myosin fluorescence changes at [ATP] given in
the figure as mM. (E) Fast (circles) and slow
(squares) phases of cardiac S1-ATP dissociation
from regulated actin. (Inset) fa (fraction of total
amplitude contributed by the fast component) vs.
[ATP]. (F) Apparent rate constants for the acrylo-
dan-tropomyosin fluorescence transitions for the
slow phase and fast phase (inset). Conditions:
2 mM actin, 0.86 mM acrylodan-tropomyosin,
0.86 mM troponin (human cardiac TnT and TnC
with mouse cardiac TnI), and 2 mM S1 in the
same buffer as in Fig. 3.
The C-Terminus of Troponin T 2541of cardiac S1. The apparent rate constants of both the fast
and slow processes were reduced compared with those
measured with skeletal S1 (Fig. 4 C) as a result of reduced
cardiac S1 detachment kinetics. Skeletal S1 was used in
subsequent studies because of its more rapid detachment
kinetics.
Fig. 5 compares the acrylodan tropomyosin transients of
regulated actin containing various types of troponin. In all
cases, the presence of D14 TnT virtually eliminated the
slow fluorescence change associated with transition to the
inactive state. Fig. 5 A shows acrylodan tropomyosin fluo-
rescence transients in EGTA for studies with skeletal S1,
human cardiac TnT and TnC, and mouse cardiac TnI. Regu-
lated actin containing either wild-type troponin or troponin
containing S45E TnI exhibited the fluorescence increase
indicative of formation of the inactive state. Regulated actin
containing D14 TnT did not exhibit the slow fluorescence
increase. The presence of the S45E TnI mutant did not
rescue the fluorescence increase in the presence of D14
TnT. These observations were made at 2, 7, 11, 15,
and 20C, but only those at 11C are shown.
Fig. 5 B shows the transition among the states of regulated
actin for studies done with skeletal S1 and human cardiac
TnI. Fig. 5 C shows similar studies with cardiac S1 and
human cardiac TnI. In both cases, regulated actin containing
wild-type troponin exhibited a rapid fluorescence decrease
followed by a slower increase showing a robust transition
to the inactive state. When the 14 C-terminal residues of
TnT were absent, the signal was attenuated and little, if
any, transition to the inactive state occurred.FIGURE 5 Transition of actin-tropomyosin-troponin from the active
state to the intermediate and inactive states after rapid dissociation of
S1-ATP. (A) Measurements with skeletal S1, human cardiac TnT, and
TnC and mouse cardiac TnI at 11C. kapp (slow phase) ¼ 9.1/s for wild-
type and 12.0/s for S45E. (B) Measurements with skeletal S1 and human
cardiac troponin subunits at 7C. kapp (slow phase) ¼ 10.5/s for wild-
type. (C) Measurements with cardiac S1 and human cardiac troponin
subunits at 7C. kapp (slow phase) ¼ 5.1/s for wild-type. Conditions:
2 mM actin, 0.86 mM acrylodan-tropomyosin, 0.86 mM troponin, 2 mM
S1, and 2 mM ATP in the same buffer as in Fig. 3.DISCUSSION
The key observation in this report is that deletion of the 14
C-terminal residues of cardiac TnT greatly reduced or elim-
inated the occupancy of the inactive or blocked state. This
conclusion was based on enhanced activation of ATPase
activity in the absence and presence of calcium and changes
in acrylodan-tropomyosin fluorescence.
Upon dissociating S1-ATP from regulated actin filaments
containing acrylodan-labeled tropomyosin there is a rapid
decrease in fluorescence followed by a slower fluorescence
increase (21). The initial fluorescence phase is due to a tran-
sition from the active state to the intermediate state whereas
the second phase monitors the transition to the inactive state.
In the case of D14 TnT-containing regulated actin, there was
little or no evidence of the second phase even in the presence
of S45E TnI that favors the inactive state.
Measurements of the fluorescence transitions require that
the binding of ATP to S1 and the subsequent dissociation of
S1 from regulated actin be rapid compared to the two subse-
quent fluorescence transitions. Skeletal S1 dissociates
rapidly. The kinetics and amplitude of the transition from
the intermediate state to the inactive state are reliable,
although the rate constant for the transition from the activeBiophysical Journal 102(11) 2536–2544
2542 Franklin et al.state to the intermediate state could be underestimated.
Cardiac S1-ATP dissociation, on the other hand, had
a slow phase that interfered with measurement of both fluo-
rescence transitions. That slow phase may have resulted
from b-cardiac S1 that has a 5–10-fold higher affinity for
actin than the a-isoform (29).
Simulations of the transitions indicated that, as the rate
constant for S1-ATP release decreased below 200/s, the
second fluorescence transient became smaller. When the
rate constant for S1-ATP release reached 50/s the second
transient was 50% of its true value. The apparent rate
constant for the second phase of cardiac S1 dissociation
was 30/s. Therefore, measurements made with skeletal S1
are more reliable.
The C-terminal 14 residues of TnT appear to be essential
for stabilizing the inactive state and/or for generating the
signal indicative of the inactive state or both. The acrylodan
probe is present at Cys-190 of tropomyosin. There is
evidence that the C-terminal region of TnT binds near that
region (30) but is disrupted when Ca2þ is bound to the regu-
latory lobe of troponin C (31).
There is evidence that the region of TnT that binds near
Cys-190 is within the C-terminal 31 (31) or 17 residues
(32) of troponin T. If true, then the slower increase in acryl-
odan fluorescence that we observe could be due to binding
of the C-terminal region of TnT to area near the acrylodan
probe. However, another study localized the TnT2 tropomy-
osin-binding region to a 25-amino-acid segment of TnT near
the beginning of the TnT2 region (between residues 197 and
239 for human cTnT) (33).
Evidence that the slower increase in acrylodan fluores-
cence is indicative of formation of the inactive/blocked state
comes from past (21) and present correlations of the fluores-
cence changes with ATPase activity. Regulated actin can be
trapped in the active/M state in the absence of Ca2þ by rigor
S1 binding. After rapid S1-ATP dissociation, the regulated
actin returns to its most stable state—the inactive/blocked
state. This occurs with a rapid decrease in fluorescence fol-
lowed by a slower fluorescence increase. That slower
increase occurs only in the absence of Ca2þ where the inac-
tive state forms (21). We saw that, when the C-terminal 14
residues of TnT are absent, the slow fluorescence increase
did not occur.
We also observed, with highly reproducible skeletal S1
ATPase activities, that actin filaments containing D14 TnT
had an ATPase rate greater than wild-type actin filaments
in the absence of Ca2þ. Those ATPase rates indicated that
actin filaments containing D14 TnT were not in the fully
inactive state. Rather, the results are consistent with the
D14 TnT-regulated actin existing in the intermediate/closed
state in the absence of Ca2þ.
Table 1 shows that in EGTA, regulated actin containing
D14 TnT has ~1.5% of the ability to stimulate ATP hydro-
lysis as filaments in the fully active state. That agrees with
estimates of the relative activating ability of the interme-Biophysical Journal 102(11) 2536–2544diate state determined from an analysis of the properties
of R146G and R146W mutants of TnI that stabilize the
intermediate state (1). The earlier estimate placed the ratio
of activity of the intermediate state to the NEM-S1 activated
rate to be between 0.04 and 0.15. That corresponds to
normalized rates between 1.4 and 2.2% using the method
of calculation given in Table 1.
The low ability of the intermediate state of regulated actin
to stimulate myosin ATPase activity means that there are
two inactive states. Multiple inactive states may act as
a reservoir to lower the population of the active state. The
transition from the inactive state to the intermediate state
is sensitive to Ca2þ and to high affinity S1 (i.e., S1-ADP)
binding whereas the transition of the intermediate state to
the active state is sensitive only to high affinity S1 binding
(i.e., S1-ADP). This arrangement gives multiple control
points and may be involved in phosphorylation-dependent
modulation of cardiac regulation (34).
The experimental difficulty with multiple inactive states
is that it can be difficult to determine which state is occupied
in a particular situation. By normalizing the activities as in
Table 1 it is possible to detect small changes in activity.
Changes in acrylodan-tropomyosin fluorescence as shown
in Figs. 3–5 present a convenient signature for detecting
changes in the inactive state.
Our results are consistent with earlier measurements
made with C-terminal truncation mutants of TnT. When
examined in rabbit psoas fibers, D14 TnT did not signifi-
cantly affect force, but increased Ca2þ sensitivity (3).
Increased Ca2þ sensitivity was also observed for another
TnT truncation mutant, D28þ7 (35,36). The increased
Ca2þ sensitivity is consistent with destabilization of the
inactive state and stabilization of the active state. In trans-
genic mice, the D28þ7 TnT mutation resulted in impaired
diastolic and systolic function (37). The inability to relax
completely may be due in part to loss of the inactive/blocked
state. Reduced inhibition of in vitro motility was observed
for actin filaments containing D28þ7 TnT (38). This is
another example where modifications of the C-terminal
region of TnT prevent full relaxation.
A possible scenario for the interactions that stabilize the
inactive state is shown in Fig. 6. Binding of the inhibitory
region of TnI to actin is thought to be essential for holding
tropomyosin in the inactive state (39–42). The C-terminal
region of TnI (C-TnI) also binds to the interhelical region
of actin in the inhibited state (43). We show here that the
C-terminus of TnT (C-TnT) or specifically the region
SKTRGKAKVTGRWK is also required to have a stable
inactive state. This region is within the C-terminal 17-
amino-acid region that is unstructured (42). Based on
evidence given earlier in this discussion, that C-terminal
region of TnT may bind to tropomyosin near Cys-190 within
period 5. The inhibitory and switch regions of TnI (40,41)
are also near the period-5 region of tropomyosin (44)
when regulated actin is in the inactive state.
FIGURE 6 Schematic of possible interactions of TnI and TnTwith actin-
tropomyosin in the relaxed state. The scheme is based on the published
crystal structure of the core region of troponin (42). Only that portion of
the regulatory complex containing the interaction sites is shown. TnC is
shown as a dumbbell. (Bold lines)Two of the TnI helices and the inhibitory
region (IR), the switch region (SW), and the C-terminal region between
residues 164 and 210 (C-TnI) are shown. (Black) TnT helix and the
C-terminal region encompassing residues 271–288 (C-TnT). (Parallel
dotted lines) Putative interactions with actin and tropomyosin in the
absence of Ca2þ. (Asterisk) Cys-190 of tropomyosin.
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